[1]
H. Kim, H. J. Kim, Y. T. Park, and J. S. Kim, “Clinical Significance of Sphingosine 1-phosphate Receptor 2 and Takeda G Protein-coupled Receptor 5 in Extrahepatic Cholangiocarcinoma Patients”, JGLD, vol. 32, no. 3, pp. 371-376, Sep. 2023.